Brief: 89Bio Initiates Phase 3 Entrust Trial Of Pegozafermin In Patients With Severe Hypertriglyceridemia (SHTG)

89bio

23/05/2023 13:19

May 23 (Reuters) - 89Bio Inc  ETNB.O :
    * 89BIO INITIATES PHASE 3 ENTRUST TRIAL OF PEGOZAFERMIN IN
PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHTG)

Source text for Eikon:  ID:nGNX432CYp 
Further company coverage:  ETNB.O 

 ((reuters.briefs@thomsonreuters.com;))